Magdalena Gorska
Concepts (355)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estradiol | 6 | 2016 | 518 | 2.240 |
Why?
| | Th2 Cells | 9 | 2024 | 176 | 2.240 |
Why?
| | Asthma | 22 | 2025 | 2282 | 2.190 |
Why?
| | Osteosarcoma | 5 | 2016 | 74 | 1.900 |
Why?
| | Vehicle Emissions | 3 | 2020 | 67 | 1.610 |
Why?
| | Nitric Oxide Synthase Type I | 3 | 2015 | 28 | 1.400 |
Why?
| | Adaptor Proteins, Signal Transducing | 8 | 2012 | 429 | 1.400 |
Why?
| | Killer Cells, Natural | 4 | 2020 | 443 | 1.320 |
Why?
| | Maternal Exposure | 4 | 2020 | 188 | 1.280 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 4 | 2021 | 21 | 0.980 |
Why?
| | Hypersensitivity | 2 | 2024 | 257 | 0.890 |
Why?
| | Bone Neoplasms | 3 | 2016 | 248 | 0.860 |
Why?
| | Interleukin-17 | 4 | 2020 | 119 | 0.810 |
Why?
| | Lymphocytes | 6 | 2025 | 393 | 0.790 |
Why?
| | Lactams, Macrocyclic | 2 | 2013 | 49 | 0.790 |
Why?
| | Benzoquinones | 2 | 2013 | 48 | 0.780 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2020 | 605 | 0.690 |
Why?
| | Antineoplastic Agents | 4 | 2016 | 2123 | 0.680 |
Why?
| | Allergens | 7 | 2025 | 408 | 0.670 |
Why?
| | Granzymes | 1 | 2020 | 51 | 0.670 |
Why?
| | Mutation, Missense | 2 | 2012 | 337 | 0.660 |
Why?
| | Oxidative Stress | 6 | 2016 | 1314 | 0.620 |
Why?
| | Signal Transduction | 14 | 2025 | 5077 | 0.600 |
Why?
| | Mice | 25 | 2025 | 17759 | 0.580 |
Why?
| | Chaperonin 60 | 2 | 2016 | 14 | 0.560 |
Why?
| | Protein Tyrosine Phosphatases | 5 | 2016 | 172 | 0.550 |
Why?
| | Bronchial Hyperreactivity | 5 | 2015 | 111 | 0.550 |
Why?
| | Heat-Shock Proteins | 2 | 2016 | 142 | 0.530 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2016 | 127 | 0.520 |
Why?
| | Estrogen Antagonists | 1 | 2016 | 45 | 0.500 |
Why?
| | Estrogen Receptor beta | 1 | 2016 | 40 | 0.500 |
Why?
| | Apoptosis | 6 | 2016 | 2552 | 0.490 |
Why?
| | DNA Breaks | 1 | 2015 | 3 | 0.480 |
Why?
| | Interleukin-1beta | 1 | 2017 | 371 | 0.480 |
Why?
| | Bacterial Outer Membrane Proteins | 4 | 2016 | 58 | 0.480 |
Why?
| | Animals | 30 | 2025 | 36850 | 0.470 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2016 | 161 | 0.460 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 256 | 0.460 |
Why?
| | Neuroblastoma | 1 | 2016 | 160 | 0.450 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2021 | 455 | 0.450 |
Why?
| | Virus Diseases | 1 | 2017 | 213 | 0.450 |
Why?
| | Protein Processing, Post-Translational | 5 | 2016 | 465 | 0.440 |
Why?
| | Cell Line, Tumor | 8 | 2016 | 3406 | 0.440 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2011 | 718 | 0.430 |
Why?
| | Leukocyte Common Antigens | 4 | 2015 | 87 | 0.430 |
Why?
| | Neurodegenerative Diseases | 1 | 2016 | 136 | 0.420 |
Why?
| | Cytokines | 7 | 2024 | 2084 | 0.410 |
Why?
| | Hippocampus | 2 | 2015 | 894 | 0.410 |
Why?
| | Cell Survival | 8 | 2016 | 1116 | 0.410 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 434 | 0.400 |
Why?
| | Immunity, Innate | 5 | 2024 | 825 | 0.400 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2021 | 1095 | 0.400 |
Why?
| | Lymphopenia | 1 | 2012 | 62 | 0.390 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2012 | 46 | 0.380 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2011 | 7 | 0.380 |
Why?
| | Inflammation | 2 | 2017 | 2835 | 0.370 |
Why?
| | Cell Proliferation | 9 | 2021 | 2476 | 0.360 |
Why?
| | Lymphocyte Activation | 6 | 2021 | 1150 | 0.360 |
Why?
| | Disease Models, Animal | 8 | 2022 | 4282 | 0.350 |
Why?
| | Neoplasms | 2 | 2016 | 2643 | 0.340 |
Why?
| | Drug Screening Assays, Antitumor | 3 | 2016 | 195 | 0.330 |
Why?
| | rab GTP-Binding Proteins | 2 | 2010 | 75 | 0.320 |
Why?
| | Humans | 47 | 2025 | 136803 | 0.320 |
Why?
| | Immunological Synapses | 1 | 2009 | 16 | 0.320 |
Why?
| | Interleukin-13 | 3 | 2020 | 149 | 0.310 |
Why?
| | Membrane Proteins | 3 | 2025 | 1163 | 0.310 |
Why?
| | Cell Differentiation | 4 | 2020 | 1982 | 0.310 |
Why?
| | Ovalbumin | 3 | 2022 | 183 | 0.310 |
Why?
| | Hydrogen Peroxide | 4 | 2015 | 327 | 0.300 |
Why?
| | Air Pollutants | 1 | 2013 | 427 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 5 | 2021 | 152 | 0.290 |
Why?
| | Mice, Knockout | 7 | 2025 | 3009 | 0.270 |
Why?
| | Interleukin-5 | 2 | 2008 | 44 | 0.260 |
Why?
| | Capillary Permeability | 1 | 2007 | 145 | 0.260 |
Why?
| | Dynamin II | 1 | 2006 | 4 | 0.250 |
Why?
| | Mice, Inbred BALB C | 5 | 2022 | 1269 | 0.250 |
Why?
| | Aurintricarboxylic Acid | 2 | 2016 | 4 | 0.250 |
Why?
| | Bronchoalveolar Lavage | 2 | 2018 | 93 | 0.250 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 2 | 2015 | 10 | 0.240 |
Why?
| | Neutrophils | 2 | 2025 | 1236 | 0.240 |
Why?
| | Respiratory Tract Diseases | 1 | 2007 | 184 | 0.240 |
Why?
| | Immunoglobulin E | 3 | 2018 | 342 | 0.230 |
Why?
| | T-Lymphocytes | 4 | 2009 | 1993 | 0.230 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2016 | 2052 | 0.220 |
Why?
| | Th17 Cells | 2 | 2016 | 109 | 0.220 |
Why?
| | Transforming Growth Factor beta | 4 | 2012 | 480 | 0.220 |
Why?
| | Cell Death | 2 | 2016 | 372 | 0.220 |
Why?
| | Jurkat Cells | 5 | 2015 | 134 | 0.210 |
Why?
| | Disease Susceptibility | 2 | 2017 | 345 | 0.210 |
Why?
| | Cells, Cultured | 7 | 2020 | 4192 | 0.210 |
Why?
| | Gene Expression Regulation | 4 | 2015 | 2605 | 0.210 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1242 | 0.210 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 2022 | 655 | 0.210 |
Why?
| | Mast Cells | 1 | 2024 | 147 | 0.210 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 5750 | 0.210 |
Why?
| | NF-kappa B | 1 | 2007 | 691 | 0.210 |
Why?
| | Catalytic Domain | 4 | 2016 | 207 | 0.200 |
Why?
| | MAP Kinase Signaling System | 4 | 2021 | 320 | 0.200 |
Why?
| | Molecular Docking Simulation | 4 | 2016 | 113 | 0.190 |
Why?
| | MAP Kinase Kinase 1 | 2 | 2012 | 75 | 0.180 |
Why?
| | Immune System | 1 | 2003 | 177 | 0.180 |
Why?
| | Pregnancy | 4 | 2020 | 6729 | 0.180 |
Why?
| | Pleurotus | 1 | 2021 | 1 | 0.180 |
Why?
| | src-Family Kinases | 4 | 2012 | 92 | 0.180 |
Why?
| | Phosphorylation | 5 | 2021 | 1758 | 0.170 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2016 | 528 | 0.170 |
Why?
| | Nitric Oxide | 2 | 2016 | 915 | 0.170 |
Why?
| | Interleukin-33 | 2 | 2017 | 50 | 0.170 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2020 | 12 | 0.170 |
Why?
| | Receptors, Prostaglandin | 1 | 2020 | 22 | 0.170 |
Why?
| | Protein Transport | 2 | 2013 | 443 | 0.160 |
Why?
| | Enzyme Activation | 6 | 2012 | 810 | 0.160 |
Why?
| | Carrier Proteins | 1 | 2004 | 769 | 0.160 |
Why?
| | Protein Binding | 7 | 2016 | 2216 | 0.160 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 2 | 2016 | 44 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 3 | 2010 | 185 | 0.150 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 2 | 2016 | 47 | 0.150 |
Why?
| | Immunologic Memory | 1 | 2021 | 370 | 0.150 |
Why?
| | Colonic Neoplasms | 1 | 2021 | 256 | 0.150 |
Why?
| | Receptors, Immunologic | 1 | 2020 | 216 | 0.150 |
Why?
| | Female | 17 | 2025 | 72816 | 0.150 |
Why?
| | DNA | 1 | 2025 | 1458 | 0.150 |
Why?
| | Interleukin-9 | 1 | 2017 | 9 | 0.140 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2017 | 26 | 0.140 |
Why?
| | Macrophages | 1 | 2025 | 1544 | 0.140 |
Why?
| | Immunization | 2 | 2018 | 411 | 0.140 |
Why?
| | Virulence Factors | 2 | 2016 | 166 | 0.130 |
Why?
| | Adoptive Transfer | 3 | 2021 | 224 | 0.130 |
Why?
| | Enzyme Inhibitors | 3 | 2015 | 839 | 0.130 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 87 | 0.130 |
Why?
| | Endocytosis | 2 | 2009 | 169 | 0.130 |
Why?
| | Yersinia | 1 | 2016 | 2 | 0.130 |
Why?
| | Toluidines | 1 | 2016 | 7 | 0.130 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2016 | 16 | 0.130 |
Why?
| | Enzyme Induction | 2 | 2014 | 90 | 0.130 |
Why?
| | Rosaniline Dyes | 1 | 2016 | 13 | 0.130 |
Why?
| | Benzenesulfonates | 1 | 2016 | 22 | 0.130 |
Why?
| | Acetylation | 2 | 2016 | 248 | 0.130 |
Why?
| | Drug Resistance | 1 | 2017 | 169 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 657 | 0.130 |
Why?
| | Caffeic Acids | 1 | 2016 | 2 | 0.130 |
Why?
| | Yersinia enterocolitica | 1 | 2016 | 7 | 0.130 |
Why?
| | Succinates | 1 | 2016 | 22 | 0.130 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2016 | 71 | 0.120 |
Why?
| | Microtubule Proteins | 2 | 2007 | 16 | 0.120 |
Why?
| | Tubulin Modulators | 1 | 2015 | 9 | 0.120 |
Why?
| | Ferrous Compounds | 1 | 2015 | 23 | 0.120 |
Why?
| | Cell Culture Techniques | 2 | 2016 | 362 | 0.120 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 98 | 0.120 |
Why?
| | Tumor Suppressor p53-Binding Protein 1 | 1 | 2015 | 13 | 0.120 |
Why?
| | Peroxides | 1 | 2015 | 19 | 0.120 |
Why?
| | Reactive Nitrogen Species | 1 | 2015 | 21 | 0.120 |
Why?
| | M Phase Cell Cycle Checkpoints | 1 | 2015 | 24 | 0.120 |
Why?
| | Cell Line, Transformed | 1 | 2015 | 145 | 0.120 |
Why?
| | Calcifediol | 1 | 2015 | 33 | 0.120 |
Why?
| | Drug Synergism | 1 | 2016 | 383 | 0.120 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2012 | 123 | 0.120 |
Why?
| | Antibodies, Blocking | 1 | 2015 | 33 | 0.120 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 153 | 0.120 |
Why?
| | Cytokinesis | 1 | 2015 | 48 | 0.110 |
Why?
| | Cellular Senescence | 1 | 2016 | 187 | 0.110 |
Why?
| | Estrogen Receptor alpha | 1 | 2016 | 145 | 0.110 |
Why?
| | Doxorubicin | 1 | 2016 | 362 | 0.110 |
Why?
| | Mucus | 2 | 2017 | 79 | 0.110 |
Why?
| | CD4 Lymphocyte Count | 2 | 2012 | 269 | 0.110 |
Why?
| | Transcription, Genetic | 2 | 2013 | 1455 | 0.110 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 216 | 0.110 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2016 | 283 | 0.110 |
Why?
| | Growth Inhibitors | 2 | 2012 | 43 | 0.110 |
Why?
| | Histones | 2 | 2016 | 636 | 0.110 |
Why?
| | Molecular Dynamics Simulation | 4 | 2016 | 211 | 0.110 |
Why?
| | Immune Tolerance | 2 | 2009 | 362 | 0.110 |
Why?
| | Lung | 2 | 2022 | 4063 | 0.110 |
Why?
| | Interleukin-4 | 2 | 2014 | 216 | 0.110 |
Why?
| | Vitamins | 1 | 2015 | 185 | 0.110 |
Why?
| | Alternaria | 2 | 2025 | 13 | 0.110 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2013 | 56 | 0.100 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 657 | 0.100 |
Why?
| | Swine | 1 | 2016 | 773 | 0.100 |
Why?
| | Myristic Acids | 1 | 2012 | 8 | 0.100 |
Why?
| | Interleukins | 1 | 2015 | 251 | 0.100 |
Why?
| | Myristic Acid | 1 | 2012 | 10 | 0.100 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2012 | 16 | 0.100 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2012 | 15 | 0.100 |
Why?
| | Carcinogenesis | 1 | 2015 | 217 | 0.100 |
Why?
| | Retinal Dystrophies | 1 | 2012 | 5 | 0.100 |
Why?
| | Pre-Eclampsia | 1 | 2015 | 189 | 0.100 |
Why?
| | DNA Damage | 1 | 2015 | 420 | 0.100 |
Why?
| | Severe Combined Immunodeficiency | 1 | 2012 | 20 | 0.100 |
Why?
| | Novobiocin | 1 | 2012 | 5 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2012 | 45 | 0.100 |
Why?
| | Biomarkers | 3 | 2020 | 4145 | 0.100 |
Why?
| | Macrolides | 1 | 2012 | 63 | 0.090 |
Why?
| | Models, Biological | 2 | 2012 | 1773 | 0.090 |
Why?
| | Pyrrolidinones | 1 | 2011 | 28 | 0.090 |
Why?
| | Tissue Engineering | 1 | 2016 | 418 | 0.090 |
Why?
| | Endosomes | 2 | 2010 | 136 | 0.090 |
Why?
| | Culture Media | 1 | 2011 | 165 | 0.090 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2012 | 132 | 0.090 |
Why?
| | Triazoles | 1 | 2012 | 147 | 0.090 |
Why?
| | Age of Onset | 1 | 2012 | 518 | 0.090 |
Why?
| | Biosensing Techniques | 1 | 2011 | 122 | 0.080 |
Why?
| | Enzyme Stability | 1 | 2010 | 70 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1396 | 0.080 |
Why?
| | Actins | 2 | 2009 | 416 | 0.080 |
Why?
| | Dynamins | 1 | 2009 | 37 | 0.080 |
Why?
| | Eosinophils | 2 | 2012 | 332 | 0.080 |
Why?
| | Ambrosia | 1 | 2009 | 7 | 0.080 |
Why?
| | Aspergillus | 1 | 2009 | 17 | 0.080 |
Why?
| | Pyroglyphidae | 1 | 2009 | 19 | 0.080 |
Why?
| | Th1 Cells | 1 | 2010 | 143 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 1225 | 0.080 |
Why?
| | Gene Expression Profiling | 2 | 2013 | 1772 | 0.080 |
Why?
| | Interleukin-2 | 1 | 2010 | 455 | 0.080 |
Why?
| | Indoles | 1 | 2012 | 410 | 0.080 |
Why?
| | Myosins | 1 | 2009 | 132 | 0.080 |
Why?
| | RNA, Small Interfering | 2 | 2010 | 622 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2010 | 302 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2016 | 1094 | 0.070 |
Why?
| | Arthritis, Experimental | 1 | 2010 | 147 | 0.070 |
Why?
| | Antigen Presentation | 1 | 2009 | 216 | 0.070 |
Why?
| | eIF-2 Kinase | 1 | 2008 | 31 | 0.070 |
Why?
| | Cytoskeleton | 1 | 2009 | 188 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2009 | 163 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.070 |
Why?
| | HSP27 Heat-Shock Proteins | 1 | 2007 | 14 | 0.070 |
Why?
| | GATA3 Transcription Factor | 2 | 2020 | 26 | 0.070 |
Why?
| | Umbilical Veins | 1 | 2007 | 61 | 0.070 |
Why?
| | Transfection | 2 | 2007 | 941 | 0.070 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2007 | 139 | 0.070 |
Why?
| | Eye Proteins | 1 | 2007 | 92 | 0.070 |
Why?
| | Inflammation Mediators | 1 | 2010 | 513 | 0.070 |
Why?
| | Mitochondria | 1 | 2013 | 946 | 0.070 |
Why?
| | Recombinant Proteins | 2 | 2015 | 1350 | 0.070 |
Why?
| | Feedback | 1 | 2007 | 172 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 313 | 0.060 |
Why?
| | Rhinitis, Allergic, Perennial | 1 | 2006 | 23 | 0.060 |
Why?
| | Bronchi | 1 | 2008 | 260 | 0.060 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2006 | 139 | 0.060 |
Why?
| | Adult | 7 | 2021 | 37643 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 2004 | 534 | 0.060 |
Why?
| | Phosphoproteins | 1 | 2008 | 337 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 171 | 0.060 |
Why?
| | Neurons | 1 | 2014 | 1587 | 0.060 |
Why?
| | Respiratory Mucosa | 1 | 2008 | 322 | 0.060 |
Why?
| | Tyrosine | 1 | 2006 | 222 | 0.060 |
Why?
| | Down-Regulation | 2 | 2021 | 656 | 0.060 |
Why?
| | Mice, Transgenic | 1 | 2010 | 2163 | 0.060 |
Why?
| | Molecular Structure | 2 | 2016 | 489 | 0.060 |
Why?
| | Flow Cytometry | 3 | 2014 | 1180 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1059 | 0.050 |
Why?
| | Cell Line | 3 | 2016 | 2838 | 0.050 |
Why?
| | src Homology Domains | 1 | 2004 | 41 | 0.050 |
Why?
| | Rats | 2 | 2010 | 5639 | 0.050 |
Why?
| | Nerve Tissue Proteins | 2 | 2009 | 595 | 0.050 |
Why?
| | Middle Aged | 7 | 2021 | 33239 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2489 | 0.050 |
Why?
| | Helminth Proteins | 1 | 2002 | 24 | 0.050 |
Why?
| | Antigen-Presenting Cells | 1 | 2003 | 156 | 0.050 |
Why?
| | Fibroblasts | 1 | 2007 | 993 | 0.050 |
Why?
| | Kinetics | 2 | 2015 | 1664 | 0.050 |
Why?
| | Severity of Illness Index | 3 | 2017 | 2822 | 0.040 |
Why?
| | Mutation | 1 | 2012 | 3947 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2007 | 926 | 0.040 |
Why?
| | Phytotherapy | 1 | 2021 | 83 | 0.040 |
Why?
| | Heat-Shock Response | 1 | 2021 | 77 | 0.040 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2002 | 198 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2020 | 164 | 0.040 |
Why?
| | NIH 3T3 Cells | 2 | 2009 | 144 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 228 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2003 | 846 | 0.030 |
Why?
| | Respiratory Hypersensitivity | 1 | 2017 | 69 | 0.030 |
Why?
| | Chaperonins | 1 | 2016 | 6 | 0.030 |
Why?
| | Serum Amyloid A Protein | 1 | 2016 | 32 | 0.030 |
Why?
| | Young Adult | 2 | 2010 | 13129 | 0.030 |
Why?
| | RNA | 1 | 2003 | 921 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2021 | 559 | 0.030 |
Why?
| | Complement C3a | 1 | 2016 | 42 | 0.030 |
Why?
| | Ubiquitination | 1 | 2016 | 102 | 0.030 |
Why?
| | Chlorogenic Acid | 1 | 2016 | 3 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 167 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.030 |
Why?
| | Chronic Disease | 2 | 2015 | 1786 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 177 | 0.030 |
Why?
| | Breeding | 1 | 2016 | 63 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2017 | 319 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 329 | 0.030 |
Why?
| | Child | 1 | 2016 | 21819 | 0.030 |
Why?
| | Peracetic Acid | 1 | 2015 | 5 | 0.030 |
Why?
| | Aged | 3 | 2010 | 23808 | 0.030 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2015 | 9 | 0.030 |
Why?
| | Cell Extracts | 1 | 2015 | 21 | 0.030 |
Why?
| | Enzyme Assays | 1 | 2015 | 24 | 0.030 |
Why?
| | Male | 6 | 2025 | 67330 | 0.030 |
Why?
| | Yersinia pestis | 1 | 2015 | 45 | 0.030 |
Why?
| | Arachidonic Acid | 1 | 2015 | 120 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2017 | 595 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2015 | 145 | 0.030 |
Why?
| | Phenotype | 1 | 2003 | 3189 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 77 | 0.030 |
Why?
| | Plague | 1 | 2015 | 60 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2015 | 135 | 0.030 |
Why?
| | Airway Remodeling | 1 | 2015 | 64 | 0.030 |
Why?
| | Cysteine | 1 | 2016 | 204 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 266 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 407 | 0.030 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 287 | 0.030 |
Why?
| | Bronchoscopy | 1 | 2014 | 223 | 0.030 |
Why?
| | Adolescent | 2 | 2010 | 21385 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 860 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2016 | 886 | 0.020 |
Why?
| | Carboxylic Acids | 1 | 2012 | 34 | 0.020 |
Why?
| | Binding Sites | 1 | 2016 | 1301 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2012 | 185 | 0.020 |
Why?
| | Dexamethasone | 1 | 2014 | 368 | 0.020 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2011 | 19 | 0.020 |
Why?
| | Gene Silencing | 1 | 2012 | 195 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2011 | 96 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1059 | 0.020 |
Why?
| | Models, Molecular | 1 | 2016 | 1570 | 0.020 |
Why?
| | Clonal Anergy | 1 | 2010 | 52 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2010 | 116 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2014 | 593 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 388 | 0.020 |
Why?
| | Cell Separation | 1 | 2010 | 317 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3540 | 0.020 |
Why?
| | GTP Phosphohydrolases | 1 | 2009 | 93 | 0.020 |
Why?
| | Placenta | 1 | 2015 | 749 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2008 | 26 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 851 | 0.020 |
Why?
| | Autocrine Communication | 1 | 2008 | 41 | 0.020 |
Why?
| | Bacteria | 1 | 2015 | 854 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1249 | 0.020 |
Why?
| | Antibody Specificity | 1 | 2008 | 189 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 162 | 0.020 |
Why?
| | Algorithms | 1 | 2015 | 1690 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2751 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 316 | 0.020 |
Why?
| | Methacholine Chloride | 1 | 2006 | 52 | 0.020 |
Why?
| | Bronchial Provocation Tests | 1 | 2006 | 51 | 0.020 |
Why?
| | Nasal Mucosa | 1 | 2006 | 107 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 484 | 0.020 |
Why?
| | Gene Expression | 1 | 2010 | 1500 | 0.010 |
Why?
| | Blood Vessels | 1 | 2006 | 187 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 844 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 2007 | 399 | 0.010 |
Why?
| | Receptors, Interleukin-5 | 1 | 2002 | 6 | 0.010 |
Why?
| | Receptors, Interleukin | 1 | 2002 | 45 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 916 | 0.010 |
Why?
| | DNA Primers | 1 | 2002 | 514 | 0.010 |
Why?
| | Comorbidity | 1 | 2006 | 1614 | 0.010 |
Why?
| | Prevalence | 1 | 2006 | 2710 | 0.010 |
Why?
| | Base Sequence | 1 | 2002 | 2179 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2138 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2894 | 0.010 |
Why?
|
|
Gorska's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|